Insulet Raises Awareness for National Diabetes Awareness Month
Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events
“We constantly hear how proud our customers are to call themselves Podders and how free and in control they feel using the Omnipod System,” said
Activities this month include:
- Beyond Type Run Team Sponsorship – Yesterday,
Insuletco-sponsored Beyond Type 1’s New York City Marathon team (“Beyond Type Run”) made up of 21 athletes, including six Omnipod users, all living and thriving with diabetes. Insuletemployees attended the race and were positioned along the marathon course to cheer on the runners, help raise awareness for diabetes, and promote the freedom the Omnipod System provides. Follow Omnipod on
- NASDAQ Closing Bell Ceremony –
Insuletwill ring the NASDAQ Stock Marketclosing bell today, November 5th. Shacey Petrovicwill speak about the importance of raising diabetes awareness and the benefits of the Omnipod System, highlighting the freedom it provides people with insulin-dependent diabetes. Dave Holmes, Podder since 2017 and member of the Beyond Type Run team, will join Shacey and employees from Insuletduring the ceremony. The NASDAQ Stock Marketclosing bell ceremony will be aired live at https://livestream.com/nasdaq/live. A video of the closing bell ceremony will be archived for one year on the NASDAQ site.
- World Diabetes Day – On
November 14th, recognized globally as World Diabetes Day (WDD), Insuletwill display its support for the advocacy community and its efforts to help raise awareness, including participation in the following events:
- Diabetes Herbsttagung 2018,
November 9th -10th in Germany.
November 14th in the Netherlands. Diabetes Professional Conference, November 14th-15th in the United Kingdom. Austrian Diabetes AssociationAnnual Meeting (ODG), November 15th-17th in Austria.
- Diabetes Herbsttagung 2018,
- Social Media –
Insuletwill feature different Podders throughout the month on the Company’s social media channels –
“With the Omnipod System, I can live as if I almost don’t have diabetes,” said
This press release may contain forward-looking statements concerning Insulet's expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, and other risks and uncertainties described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on February 22, 2018 in the section entitled "Risk Factors," and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.
Investor Relations and Corporate Communications:
Deborah R. Gordon, 978-600-7717
Vice President, Investor Relations and Corporate Communications
Natalie MacMillan, 978-600-7421
Marketing Manager, Global Public Relations & Field Programs